non-steroidal anti-inflammatory drugs gastroduodenal lesions in patients taking in the development of Helicobacter pylori Relative contribution of mucosal injury and and

@inproceedings{Hawkey2002nonsteroidalAD,
  title={non-steroidal anti-inflammatory drugs gastroduodenal lesions in patients taking in the development of Helicobacter pylori Relative contribution of mucosal injury and and},
  author={Chris J. Hawkey and J\orgen N{\ae}sdal and Ian Wilson and G{\"o}ran L{\aa}ngstr{\"o}m and A J Swannell and Rose Peacock and N D Yeomans},
  year={2002}
}
Background and aims: A past history of peptic ulceration increases the risk of an ulcer developing during non-steroidal anti-inflammatory drug (NSAID) use. Whether this is due to Helicobacter pylori infection or to reactivation of the original lesion is unclear. Methods: We used multivariate regression analyses of three large similar trials to identify factors that placed patients at high risk of ulcer development or relapse. We compared the efficacy of omeprazole 20 mg daily, misoprostol 200… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Quantitative estimation or rare adverse events which follow a biological progression . A new model applied to chronic NSAID use

  • MR Tramer, RA Moore, Reynolds DJM
  • 2000

Reply — On dissonances , Helicobacter pylori and NSAIDs

  • CJ Hawkey
  • Aliment Pharmacol Ther
  • 2000

A comparison of omeprazole and ranitidine for treating and preventing ulcers associated with non - steroidal anti - inflammatory drugs

  • ND Yeomans, Z Tulassay, L Juhasz
  • New Eng J Med
  • 1998

Similar Papers

Loading similar papers…